35-Year-Old Woman Dies of Brain Hemorrhage 11 Days After Rec…

The household of a Michigan woman says she passed away as the outcome of problems 11 days after receiving the Johnson & & Johnson(J&J) COVID vaccine.

Anne VanGeest, 35, died April 19 at Mercy Health Saint Mary’s healthcare facility in Grand Rapids from an intense subarachnoid brain hemorrhage, FOX 17 reported.

“It is with extensive unhappiness that we share the news of Anne’s passing Anne (Annie), who was 35, was a caring mother, sis, daughter and spouse,” the household stated in a statement provided by Lambert, a Grand Rapids public relations firm that is offering its services to the family pro bono.

VanGeest received the J&J shot on April 8, 5 days before the Centers for Disease Control and Prevention (CDC) paused the vaccine to investigate reports of possibly harmful embolism in females who got the shot.

VanGeest’s family said her headache began on April 16– eight days after being vaccinated. She died 3 days later. Her death certificate notes a natural death, specifically from an severe subarachnoid hemorrhage, or bleeding between the brain and tissue around the brain.

Signs of the rare blood clots normally establish six to 15 days after getting the shot.

“These initial signs are relatively unclear and nonspecific,” stated Dr. Tom Shimabukuro of the CDC COVID-19 Response. “(It’s) generally headache, however notably, the headaches for these started six or more days after vaccination.”

VanGeest’s physician submitted a report to the CDC’s Vaccine Adverse Event Reporting System (VAERS).

In an e-mail to the VanGeest family, the CDC confirmed her death had been reported to VAERS, however stated the system is not created to determine whether a reported unfavorable event was brought on by the vaccine.

“When VAERS receives reports of serious disease or death after vaccination, VAERS staff contact the hospital where the client was dealt with to obtain the associated medical records to better comprehend the adverse occasion,” the CDC stated.

According to the CDC website, “the CDC acts on any report of death to demand extra information and find out more about what occurred and to determine whether the death was an outcome of the vaccine or unassociated.”

The Defender has consistently connected to the CDC considering that March 8 to identify how investigations into reported deaths are performed, but have yet to receive an action.

On April 13, the CDC and FDA called for an immediate halt to the use of J&J’s COVID vaccine, marketed under the company’s Janssen subsidiary, while they examined at least 6 cases of a unusual and severe condition called cerebral venous thrombosis (CVT).

CVT takes place when an embolism forms in the brain’s venous sinuses. The clot avoids blood from draining pipes out of the brain. As a result, blood cells may break and leak blood into the brain tissues, forming a hemorrhage.

On April 14, the CDC’s Advisory Committee on Immunization Practices (ACIP) delayed a vote on whether to lift the time out on the J&J vaccine, successfully extending it pending additional analysis of data associating with blood clots in individuals who got the vaccine.

On April 23, the ACIP voted 10– 4 to recommend lifting the time out of the J&J shot without restrictions or an extra caution about the danger of blood clot conditions after evaluating 15 cases of rare embolism, including three deaths, according to a slide discussion shared throughout the meeting.

The ACIP said the link in between blood clots and J&J’s COVID vaccine was “plausible,” but concluded the vaccine’s advantages surpass the threats. The FDA and CDC voted to lift the pause, however the FDA said it would add a warning label about potentially severe blood clot conditions.

Denmark health officials announced Monday they would remove the J&J vaccine from the nation’s vaccine program after concluding that the advantages of the vaccine do not exceed the risk of blood clots.

On April 30 Children’s Health Defense queried the VAERS information for a series of adverse events related to the development of clotting disorders and other associated conditions. VAERS yielded a total of 1,845 reports for all 3 vaccines from Dec. 14, 2020,&through April 23. Of the 1,845 cases reported, there were 655 reports attributed to Pfizer, 577 reports to Moderna and 608 reports to J&J. Nevertheless, U.S. health authorities only acknowledged 15 blood clot cases associated with the J&J vaccine at the April 16 meeting. A query in VAERS for subarachnoid brain hemorrhage yielded 31 cases, 8 of which were related to J&J’s COVID vaccine. The post 35-Year-Old Woman Dies of Brain Hemorrhage 11 Days After Receiving J&J Vaccine appeared initially on Children’s Health Defense. This material was originally published here.